{"id":29081,"date":"2026-03-10T14:31:21","date_gmt":"2026-03-10T14:31:21","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/29081\/"},"modified":"2026-03-10T14:31:21","modified_gmt":"2026-03-10T14:31:21","slug":"breast-cancer-bc-novartis-u-s","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/29081\/","title":{"rendered":"Breast Cancer (BC) | Novartis U.S."},"content":{"rendered":"<p>Addressing the different needs around metastatic disease: Making life more than a diagnosis<\/p>\n<p>Any breast cancer diagnosis can be difficult for patients, their families, and loved ones, but\u00a0the needs of the metastatic community are greatly different, compared to those diagnosed\u00a0at an earlier stage. Metastatic breast cancer (mBC), or stage 4 breast cancer, occurs when\u00a0the disease spreads beyond the breast to other parts of the body, even after initial\u00a0treatment.15<\/p>\n<p>Did you know that it is estimated in 2025, nearly 170,000 women will be living with mBC in the\u00a0United States?16\u00a0<\/p>\n<p>Although there is currently no cure for mBC, advancements in cancer research and treatments are\u00a0helping people live longer by managing the disease as a chronic illness.\u00a0<\/p>\n<p>Novartis has partnered with the metastatic advocacy community for more than 12 years, and\u00a0remains committed to bringing much-needed support, resources, and research to mBC patients.\u00a0<\/p>\n<p>For those living with mBC, treatment teams are key to supporting treatment decision making,\u00a0and helping navigate the physical, emotional, and social challenges associated with mBC. For\u00a0more tips on living with and navigating an mBC diagnosis, check out the following available\u00a0resources:\u00a0<\/p>\n<p><a href=\"https:\/\/www.yourattentionplease.com\/sites\/yourattentionplease_com\/files\/documents\/metastatic-breast-cancer-understanding-mbc-guide.pdf\" rel=\"nofollow noopener\" target=\"_blank\">Download A Guide to Understanding Metastatic Breast Cancer (PDF)<\/a><\/p>\n<p><a href=\"https:\/\/novartis.com\/us-en\/sites\/novartis_us\/files\/170271-precision-oncology-101-patient-guide.pdf\" rel=\"nofollow noopener\" target=\"_blank\">Download Precision Oncology 101 &#8211; What You Should Know, Ask, and Remember (PDF)<\/a><\/p>\n<p>Currently approved treatments do not work the same for everyone, so patients should talk to\u00a0their doctors about treatment options. During these conversations, clinical trial results may be\u00a0discussed to help make informed choices. Additionally, new clinical trials may provide further\u00a0opportunities for treatment with investigational therapies.<\/p>\n<p>As treatments and new data become available, we strive to expand our efforts so we can\u00a0empower more people in the breast cancer community. In addition to our existing portfolio, we\u00a0are committed to researching new potential treatments to help those living with mBC.<\/p>\n","protected":false},"excerpt":{"rendered":"Addressing the different needs around metastatic disease: Making life more than a diagnosis Any breast cancer diagnosis can&hellip;\n","protected":false},"author":2,"featured_media":26657,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[127],"tags":[17685,14510,17679,17680,17675,17688,17687,17690,17674,207,4120,17691,17668,17672,17677,17676,17667,17681,17669,17670,6903,17683,17682,17684,7609,17671,206,17678,17686,10825,17689,17673],"class_list":["post-29081","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novartis","tag-your-attention","tag-access","tag-access-to-screenings","tag-access-to-treatment","tag-african-american-women-with-breast-cancer","tag-alliance","tag-alliance-for-breast-cancer","tag-alliance-steering-committee","tag-black-women-with-breast-cancer","tag-breast-cancer","tag-breast-cancer-awareness","tag-breast-cancer-coalition","tag-breast-cancer-diagnosis","tag-breast-cancer-recurrence","tag-breast-cancer-resources","tag-breast-cancer-screening","tag-breast-cancer-treatment-options","tag-clinical-trial-participation","tag-early-breast-cancer","tag-early-breast-cancer-diagnosis","tag-early-detection","tag-ebc","tag-hr-her2","tag-mbc","tag-metastatic-breast-cancer","tag-metastatic-breast-cancer-diagnosis","tag-novartis","tag-patient-outcomes","tag-please","tag-policy","tag-policy-solutions","tag-risk-of-recurrence"],"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/29081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=29081"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/29081\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/26657"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=29081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=29081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=29081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}